We have located links that may give you full text access.
American Thyroid Association Consensus Review of the Anatomy, Terminology and Rationale for Lateral Neck Dissection in Differentiated Thyroid Cancer.
Thyroid : Official Journal of the American Thyroid Association 2012 January 17
Background: Cervical lymph node metastases from differentiated thyroid cancer (DTC) are common. Thirty to eighty percent of patients with papillary thyroid cancer harbor lymph node metastases, with the central neck being the most common compartment involved. The goals of this study were to: 1) identify appropriate methods for determining metastatic DTC in the lateral neck and 2) address the extent of lymph node dissection for the lateral neck necessary to control nodal disease balanced against known risks of surgery. Methods: A literature review followed by formulation of a consensus statement by the Lateral Neck Subcommittee of the American Thyroid Association (ATA) Surgical Affairs Committee was performed. Results: Four proposals regarding management of the lateral neck are made for consideration in the next iteration of the ATA management guidelines for patients with thyroid nodules and differentiated thyroid cancer and any other future guideline proposals on DTC. Metastases to lateral neck nodes must be considered in the evaluation of the newly diagnosed thyroid cancer patient as well as for surveillance of the previously treated DTC patient. Conclusions: Lateral neck lymph nodes are a significant consideration in the surgical management of patients with DTC. When ATA guidelines are followed, initial evaluation of the DTC patient with ultrasound (or other modalities when indicated) will help to identify lateral neck lymph nodes of concern. These findings should be addressed using FNAB and a comprehensive neck dissection of at least nodal levels IIa, III, IV and Vb should be performed when indicated to optimize disease control.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app